RxDoctor Payments DataLook up a doctor →

Roberto Saenz, OD

Corneal and Contact Management · San Antonio, TXNPI 1821440280

Payments from drug & device makers

$861,497in general payments, 2019–2025

Across 395 payments — averaging $2181.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sight Sciences, Inc.$316K
  • Novartis$297K
  • Sun Pharmaceutical Industries Inc.$57K
  • Ocular Therapeutix, Inc.$48K
  • Glaukos Corporation$47K
  • Biotissue Holdings Inc.$25K
  • plus $72K from 23 others
$21,360in research payments, 2019–2025

Across 7 payments — averaging $3051.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sun Pharmaceutical Industries Inc.$17K
  • Novartis$4K

What the payments were for

  • Consulting fees$62,77537%
  • Speaking & faculty fees$87,60251%
  • Travel & lodging$10,5466%
  • Food & beverage$10,4606%
  • Gifts$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$861,497 in reported general payments places this provider in the 95th percentile of 103 corneal and contact management providers in Texas.

See all corneal and contact management providers in Texas

Medicare billing

Part B allowed, 2024
$65,910
Medicare patients
187
Services billed
643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other corneal and contact management in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →